2,378 resources
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm |
|---|---|---|---|---|---|---|---|---|
| smart.who.int.dak-ccc | R4B | ImplementationGuide/smart.who.int.dak-ccc | SMART DAK CCC | active | 2024-07 | |||
| smart.who.int.pcmt | R4 | ImplementationGuide/smart.who.int.pcmt | SMART Product Catalog | draft | 2025-07 | |||
| smart.who.int.pcmt-vaxprequal | R5 | ImplementationGuide/smart.who.int.pcmt-vaxprequal | SMART Product Dataset for Prequalified Vaccines | draft | 2025-07 | |||
| smart.who.int.trust-phw | R4 | ImplementationGuide/smart.who.int.trust-phw | GDHCN Trust Network - Personal Health Wallet | draft | 2025-07 | uv | ||
| smart.who.int.dak-immz | R4 | ImplementationGuide/smart.who.int.dak-immz | SMART DAK IMMZ | draft | 2025-04 | |||
| smart.who.int.dak-pnc | R4 | ImplementationGuide/smart.who.int.dak-pnc | SMART DAK PNC | draft | 2025-07 | |||
| smart.who.int.dak-bds | R4 | ImplementationGuide/smart.who.int.dak-bds | SMART DAK BDS | draft | 2025-07 | |||
| smart.who.int.dak-SMBP | R4 | ImplementationGuide/smart.who.int.dak-SMBP | SMART DAK SMBP | draft | 2025-06 | |||
| smart.who.int.dak-smbp | R4 | ImplementationGuide/smart.who.int.dak-smbp | SMART DAK SMBP | draft | 2025-07 | |||
| smart.who.int.ig-starter-kit | R5 | ImplementationGuide/smart.who.int.ig-starter-kit | SMART Guidelines Starter Kit | draft | 2025-05 | uv | ||
| smart.who.int.icvp | R4 | ImplementationGuide/smart.who.int.icvp | SMART ICVP | draft | 2025-07 | |||
| smart.who.int.trust | R5 | ImplementationGuide/smart.who.int.trust | WHO SMART Trust | draft | 2025-07 | uv | ||
| who.ved | R4 | ImplementationGuide/priyanka | Claim FHIR Implementation Guide | draft | uv | |||
| smart.who.int.dak-tb | R4 | ImplementationGuide/smart.who.int.dak-tb | SMART DAK TB | active | 2024-06 | |||
| smart.who.int.ra | R4 | ImplementationGuide/smart.who.int.ra | Reference Architecture | draft | 2025-07 | uv | ||
| smart.who.int.hiv | R4 | ImplementationGuide/smart.who.int.hiv | WHO SMART Guidelines - HIV | active | 2025-07 | |||
| who.ddcc | R4 | ImplementationGuide/who.ddcc | WHO Digital Documentation of COVID-19 Certificates (DDCC) | draft | 2022-03 | uv | ||
| smart.who.int.base-clinical | R4 | ImplementationGuide/smart.who.int.base-clinical | SMART Base Clinical | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | ImplementationGuide/smart.who.int.anc | WHO Antenatal Care Guideline Implementation Guide | draft | 2017-02 | uv | ||
| smart.who.int.immunizations | R4 | ImplementationGuide/smart.who.int.immunizations | WHO Immunization Implementation Guide | draft | 2024-12 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND35 | HIV.IND.35 ARV toxicity prevalence | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND41 | HIV.IND.41 ART coverage in breastfeeding mothers | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND39 | HIV.IND.39 Infant ARV prophylaxis coverage | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND38 | HIV.IND.38 Early infant diagnosis (EID) coverage | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND42 | HIV.IND.42 Final outcome of PMTCT | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND37 | HIV.IND.37 Viral suppression at labour and delivery | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND40 | HIV.IND.40 ART coverage in pregnant women | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND14 | HIV.IND.14 OAMT minimum dose | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND13 | HIV.IND.13 OAMT minimum duration | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND6 | HIV.IND.6 PEP completion | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND7 | HIV.IND.7 HIV in PEP recipients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND11 | HIV.IND.11 OAMT coverage | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND76 | HIV.IND.76 Presence of STI syndrome, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND78 | HIV.IND.78 Repeat diagnosis of STI syndrome, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND70 | HIV.IND.70 Gonorrhoea testing coverage, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND74 | HIV.IND.74 Gonorrhoea treatment coverage, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND66 | HIV.IND.66 Syphilis treatment coverage, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND83 | HIV.IND.83 HCV test coverage, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND80 | HIV.IND.80 HBV test coverage, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND62 | HIV.IND.62 Syphilis test positivity, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND58 | HIV.IND.58 Syphilis testing coverage, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND88 | HIV.IND.88 HCV positivity, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND53 | HIV.IND.53 Multi-month ARV dispensing | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND92 | HIV.IND.92 HCV cured among people living with HIV | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND90 | HIV.IND.90 HBV treatment among people living with HIV | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND91 | HIV.IND.91 HCV treatment among people living with HIV | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND77 | HIV.IND.77 Presence of STI syndrome, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND79 | HIV.IND.79 Repeat diagnosis of STI syndrome, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND57 | HIV.IND.57 Viral suppression among people living with HIV engaged in DSD ART models | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND55 | HIV.IND.55 Coverage of DSD ART models among people living with HIV on ART | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND52 | HIV.IND.52 TB treatment initiation among diagnosed | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND50 | HIV.IND.50 TB testing among those symptom-screened positive | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND51 | HIV.IND.51 TB diagnosis among those tested for TB | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND47 | HIV.IND.47 People living with HIV with active TB disease | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND48 | HIV.IND.48 TB screening coverage among new ART patients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND49 | HIV.IND.49 TB symptom-screened positive among new ART patients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND29 | HIV.IND.29 People living with HIV on ART who have suppressed viral load | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND32 | HIV.IND.32 Viral load testing coverage | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND34 | HIV.IND.34 Appropriate second viral load test after adherence counselling | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND71 | HIV.IND.71 Gonorrhoea testing coverage, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND75 | HIV.IND.75 Gonorrhoea treatment coverage, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND67 | HIV.IND.67 Syphilis treatment coverage, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND31 | HIV.IND.31 Late ART initiation | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND73 | HIV.IND.73 Gonorrhoea test positivity, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND84 | HIV.IND.84 HCV test coverage, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND81 | HIV.IND.81 HBV test coverage, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND63 | HIV.IND.63 Syphilis test positivity, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND59 | HIV.IND.59 Syphilis testing coverage, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND46 | HIV.IND.46 TB diagnostic testing type | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND89 | HIV.IND.89 HCV positivity, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND21 | HIV.IND.21 Linkage to ART | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND54 | HIV.IND.54 Uptake of DSD ART models among people living with HIV | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND3 | HIV.IND.3 PrEP coverage | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND56 | HIV.IND.56 Retention in DSD ART models | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND25 | HIV.IND.25 HIV retesting coverage | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND9 | HIV.IND.9 Regular NSP access | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND8 | HIV.IND.8 NSP coverage | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND72 | HIV.IND.72 Gonorrhoea test positivity, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND12 | HIV.IND.12 Total person-years on OAMT | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND68 | HIV.IND.68 Syphilis treatment coverage, pregnant women, first ANC visit | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND43 | HIV.IND.43 HIV prevalence among women attending ANC | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND64 | HIV.IND.64 Syphilis test positivity, pregnant women, first visit | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND65 | HIV.IND.65 Syphilis test positivity, pregnant women, any visit | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND69 | HIV.IND.69 Syphilis treatment coverage, pregnant women, any ANC visit | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND82 | HIV.IND.82 HBV test coverage, pregnant women | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND61 | HIV.IND.61 Syphilis testing coverage, pregnant women, any ANC visit | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND60 | HIV.IND.60 Syphilis testing coverage, pregnant women, first ANC visit | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND95 | HIV.IND.95 Invasive cervical cancer treatment | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND94 | HIV.IND.94 Pre-invasive cervical disease treatment | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND20 | HIV.IND.20 Individuals testing positive for HIV | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND24 | HIV.IND.24 HTS linkage to prevention | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND96 | HIV.IND.96 Cervical cancer survival | draft | 2024-08 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND01 | IMMZIND01 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND02 | IMMZIND02 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND03 | IMMZIND03 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND04 | IMMZIND04 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND05 | IMMZIND05 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND06 | IMMZIND06 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND07 | IMMZIND07 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND08 | IMMZIND08 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND09 | IMMZIND09 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND10 | IMMZIND10 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND11 | IMMZIND11 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND12 | IMMZIND12 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND13 | IMMZIND13 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND14 | IMMZIND14 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND15 | IMMZIND15 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND16 | IMMZIND16 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND17 | IMMZIND17 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND18 | IMMZIND18 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND19 | IMMZIND19 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND20 | IMMZIND20 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND21 | IMMZIND21 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND22 | IMMZIND22 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND23 | IMMZIND23 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND24 | IMMZIND24 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND25 | IMMZIND25 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND26 | IMMZIND26 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND27 | IMMZIND27 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND28 | IMMZIND28 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND29 | IMMZIND29 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND30 | IMMZIND30 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND31 | IMMZIND31 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND32 | IMMZIND32 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND33 | IMMZIND33 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND34 | IMMZIND34 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND35 | IMMZIND35 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND36 | IMMZIND36 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND37 | IMMZIND37 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND38 | IMMZIND38 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND39 | IMMZIND39 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND44 | IMMZIND44 | draft | 2025-06 | |||
| smart.who.int.immunizations | R4 | Measure/IMMZIND45 | IMMZIND45 | draft | 2025-06 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND44 | HIV.IND.44 TPT initiation | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND28 | HIV.IND.28 Total attrition from ART | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND45 | HIV.IND.45 TPT completion | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND33 | HIV.IND.33 Early viral load testing (at six months) | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND18 | HIV.IND.18 People living with HIV who know their HIV status (first 95) | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND27 | HIV.IND.27 People living with HIV on ART | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND19 | HIV.IND.19 HTS test volume and positivity | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND30 | HIV.IND.30 New ART patients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND5 | HIV.IND.5 Number of PEP recipients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND2 | HIV.IND.2 Total PrEP recipients | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND22 | HIV.IND.22 HTS partner services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND93 | HIV.IND.93 Cervical cancer screening | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND85 | HIV.IND.85 HBsAg positivity, HIV prevention services | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND86 | HIV.IND.86 HBsAg positivity, HIV-positive clients | draft | 2024-08 | |||
| smart.who.int.anc | R4 | Measure/ANCIND12 | ANC.IND.12 Percentage of pregnant women counselled and tested for HIV | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | Measure/ANCIND03 | ANC.IND.03 Percentage of pregnant women screened for syphilis during ANC | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | Measure/ANCIND02 | ANC.IND.02 Percentage of pregnant women who received iron and folic acid (IFA) supplements for 90+ days | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | Measure/ANCIND13 | ANC.IND.13 Percentage of pregnant women who received oral pre-exposure prophylaxis (PrEP) | draft | 2025-06 | uv | ||
| smart.who.int.hiv | R4 | Measure/HIVIND87 | HIV.IND.87 HBsAg positivity, pregnant women | draft | 2024-08 | |||
| smart.who.int.anc | R4 | Measure/ANCIND05 | ANC.IND.05 Percentage of pregnant women with a minimum of eight antenatal care contacts | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | Measure/ANCIND10 | ANC.IND.10 Percentage of pregnant women with an ultrasound scan before 24 weeks | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | Measure/ANCIND04 | ANC.IND.04 Percentage of pregnant women with at least four ANC contacts | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | Measure/ANCIND07 | ANC.IND.07 Percentage of pregnant women with at least one blood pressure measure during ANC | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | Measure/ANCIND08 | ANC.IND.08 Percentage of pregnant women with at least one blood pressure measure in the third trimester during ANC | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | Measure/ANCIND01 | ANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimester | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | Measure/ANCIND11 | ANC.IND.11 Percentage of women who received three doses or more of intermittent preventive therapy for malaria (IPTp) during their last pregnancy | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | Measure/ANCIND09 | ANC.IND.09 Percentage of pregnant women whose baby’s heartbeat was listened to at least once during ANC | draft | 2025-06 | uv | ||
| smart.who.int.anc | R4 | Measure/ANCIND06 | ANC.IND.06 Pregnant women who received counselling on danger signs (%) during at least one ANC contact | draft | 2025-06 | uv | ||
| smart.who.int.hiv | R4 | Measure/HIVIND15 | HIV.IND.15 VMMC scale-up | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND4 | HIV.IND.4 Volume of PrEP prescribed | draft | 2024-08 | |||
| smart.who.int.hiv | R4 | Measure/HIVIND16 | HIV.IND.16 VMMC adverse events | draft | 2024-08 | |||
| who.ddcc | R4 | OperationDefinition/DDCCQuestionnaireResponsegenerateHealthFolder | OperationDefinition for generating a health folder (DDCCFolder). | draft | 2022-01 | uv | ||
| who.ddcc | R4 | OperationDefinition/DDCCQuestionnaireResponsegenerateHealthCertificate | OperationDefinition for generating a health certificate (DDCC) that is signed. | draft | 2021-06 | uv | ||
| smart.who.int.anc | R4 | OperationDefinition/Measure-evaluate-measure | Evaluate Measure | trial-use | 1 | 2019-10 | uv | |
| who.ddcc | R4 | OperationDefinition/DDCCQuestionnaireResponserevokeHealthCertificate | OperationDefinition for revoking a health certificate (DDCC). | draft | 2021-12 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT16 | ANC.DT.16 Dietary counselling | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT14 | ANC.DT.14 Other | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT07 | ANC.DT.07 Ultrasound recommendation | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT01 | ANC.DT.01 Danger signs | active | 2025-06 | uv | ||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD5DTMeaslesCI | IMMZ.D5.DT.Measles contraindications | draft | 2025-07 | |||
| smart.who.int.hiv | R4 | PlanDefinition/HIVB2DT | HIV.B2.DT Check for signs of serious illness | draft | 2025-07 | |||
| smart.who.int.hiv | R4 | PlanDefinition/HIVC7DT | HIV.C7.DT Check for signs of serious illness | draft | 2025-07 | |||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT13 | ANC.DT.13 Tuberculosis screening | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT12 | ANC.DT.12 Urine testing | active | 2025-06 | uv | ||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTMeaslesLowTx | IMMZ.D2.DT.Measles.Low transmission | draft | 2025-07 | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD2DTMeaslesOngoingTx | IMMZ.D2.DT.Measles Ongoing Transmission | draft | 2025-07 | |||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT30 | ANC.DT.30 General risk reduction counselling | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT03 | ANC.DT.03 Check symptoms and follow up | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT11 | ANC.DT.11 Syphilis testing | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT08 | ANC.DT.08 HIV testing | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT09 | ANC.DT.09 Heptatitis B testing | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT10 | ANC.DT.10 Hepatitis C testing | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT26 | ANC.DT.26 Calcium and vitamin A supplementation | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT04 | ANC.DT.04 Conducting physical exams | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT15 | ANC.DT.15 Behaviour counselling required | active | 2025-06 | uv | ||
| smart.who.int.hiv | R4 | PlanDefinition/HIVC23DT | HIV.C23.DT Determine PEP or PrEP regimen | draft | 2025-07 | |||
| smart.who.int.hiv | R4 | PlanDefinition/HIVD12DT | HIV.D12.Determine recommended screenings and tests | draft | 2025-07 | |||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT05 | ANC.DT.05 Evaluating labour | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT33 | ANC.DT.33 Breastfeeding counselling | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT34 | ANC.DT.34 Birth preparedness counselling | active | 2025-06 | uv | ||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT35 | ANC.DT.35 Family planning counselling | active | 2025-06 | uv | ||
| smart.who.int.hiv | R4 | PlanDefinition/HIVB9DT | HIV.B9.DT Determine retest recommendation | draft | 2025-07 | |||
| smart.who.int.anc | R4 | PlanDefinition/ANCDT38 | ANC.DT.38 Deworming and malaria prophylaxis | active | 2025-06 | uv | ||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD18SBCG | IMMZD18SBCG | draft | 2025-07 | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD18SCholeraWC | IMMZ.D18.S.Cholera.WC vaccines schedule | draft | 2025-07 | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD18SCholerarBSover5 | IMMZ.D18.S.Cholera.WC-rBS vaccine 2-dose schedule | draft | 2025-07 | |||
| smart.who.int.immunizations | R4 | PlanDefinition/IMMZD18SCholerarBS2to5 | IMMZ.D18.S.Cholera.WC-rBS vaccine 3-dose schedule | draft | 2025-07 |
FHIR